All across the nation, dozens of lawsuits against manufacturers of generic drugs have been dismissed because of a decision by the U-S Supreme Court a year ago. It's a ruling that Wyomingites don't likely know about - centering on whether generic manufacturers have to update warnings about drug dangers when safety issues surface with name-brand equivalents. They're not required to do so. Attorney Gary Leppla represented the family of a young woman who had an adverse reaction to a generic medication and died. He points out that generics aren't even usually the patient's, or doctor's, choice.
Proposed legislation would force makers of generics to update the warning label when a new safety issue arises. Leppla says nearly 80 percent of all prescriptions filled in the U-S are filled with generic drugs.
Insurance companies say generic drugs save money and have the same active ingredients as the brand names. Name-brand manufacturers are required by the F-D-A to constantly update their labels.
Proposed legislation would force makers of generics to update the warning label when a new safety issue arises. Leppla says nearly 80 percent of all prescriptions filled in the U-S are filled with generic drugs.
Insurance companies say generic drugs save money and have the same active ingredients as the brand names. Name-brand manufacturers are required by the F-D-A to constantly update their labels.
No comments:
Post a Comment